Literature DB >> 6183823

Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase.

W G Laver, G M Air, R G Webster, L J Markoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6183823     DOI： 10.1016/0042-6822(82)90244-6

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  23 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.

Authors:  Matthew R Sandbulte; Kim B Westgeest; Jin Gao; Xiyan Xu; Alexander I Klimov; Colin A Russell; David F Burke; Derek J Smith; Ron A M Fouchier; Maryna C Eichelberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses.

Authors:  Donata Kalthoff; Susanne Röhrs; Dirk Höper; Bernd Hoffmann; Jessica Bogs; Jürgen Stech; Martin Beer
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 4.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

5.  Heterogeneity of neuraminidase genetic information in an H1N2 reassortant influenza virus [X-7 (F1)]. Brief report.

Authors:  L R Ritchie; R G Webster; W G Laver; G M Air
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines.

Authors:  R M Pemberton; R Jennings; T L Smith
Journal:  J Hyg (Lond)       Date:  1985-04

7.  Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.

Authors:  Kim B Westgeest; Miranda de Graaf; Mathieu Fourment; Theo M Bestebroer; Ruud van Beek; Monique I J Spronken; Jan C de Jong; Guus F Rimmelzwaan; Colin A Russell; Albert D M E Osterhaus; Gavin J D Smith; Derek J Smith; Ron A M Fouchier
Journal:  J Gen Virol       Date:  2012-06-20       Impact factor: 3.891

8.  Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.

Authors:  T Saito; G Taylor; W G Laver; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Evidence for the contribution of the host species to the extent of antigenic variation of N1 influenza virus neuraminidase.

Authors:  F Maywald; F X Bosch; M Orlich; R Rott
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

10.  Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

Authors:  E D Kilbourne; B E Johansson; B Grajower
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.